TableĀ 4

Completion rates of NIHR HTA reports by intervention type

Description criteriaDrugs Number of trials with complete intervention description (%)95% CINon-drugs Number of trials with complete intervention description (%)95% CIPsychological Number of trials with complete intervention description (%)95% CIAll Number of trials with complete intervention description (%)
Number journals15 (15.3)72 (73.5)11 (11.2)98 (100)
Setting15 (100)0.80 to 166 (91.7)0.83 to 0.969 (81.8)0.52 to 0.9590 (91.8)
Inclusion criteria15 (100)0.80 to 163 (87.5)0.78 to 0.9310 (90.9)0.62 to 0.9888 (89.8)
Exclusion criteria14 (93.3)0.70 to 0.9955 (76.4)0.65 to 0.8510 (90.9)0.62 to 0.9879 (80.6)
Baseline characteristics14 (93.3)0.70 to 0.9968 (94.4)0.87 to 0.9811 (100)0.74 to 193 (94.9)
Provider11 (73.3)0.48 to 0.8956 (77.8)0.67 to 0.8610 (90.9)0.62 to 0.9877 (78.6)
Procedure14 (93.3)0.70 to 0.9957 (79.2)0.68 to 0.879 (81.8)0.52 to 0.9580 (81.6)
Intensity13 (86.7)0.62 to 0.9663 (87.5)0.78 to 0.939 (81.8)0.52 to 0.9585 (86.8)
Schedule13 (86.7)0.62 to 0.9659 (81.9)0.71 to 0.899 (81.8)0.52 to 0.9581 (82.7)
Patient information9 (60.0)0.36 to 0.8042 (58.3)0.47 to 0.696 (54.5)0.28 to 0.7957 (58.2)
Physical materials10 (66.7)0.42 to 0.8552 (72.3)0.61 to 0.816 (54.5)0.28 to 0.7968 (69.4)
Intervention description complete overall5 (33.3)0.15 to 0.5822 (30.6)0.21 to 0.423 (27.3)0.10 to 0.5730 (30.6)
  • Some criteria are not applicable, therefore denominator less than total number of journals. 95% CI: no continuity correction.

  • HTA, Health Technology Assessment.